In addition, stroke‐related risk factors such as aging and elevated blood pressure have also been reported to significantly affect the expression of VCAM‐1 and ICAM‐1 in both ECs and peripheral immune cells [35, 36, 37, 38], further highlighting the importance of understanding the regulatory mechanisms underlying these molecules and developing targeted interventions in stroke treatment. This evidence concerns the gene VCAM1 and Stroke.